Anti-DR5 antibody [EPR19310]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(5 Reviews)
|
(19 Publications)
Rabbit Recombinant Monoclonal DR5 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 19 publications.
View Alternative Names
CD262, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186, TNFRSF10B, Tumor necrosis factor receptor superfamily member 10B, Death receptor 5, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HT1080 (Human fibrosarcoma cell line) cells labeling DR5 with ab199357 at 1/100 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HT1080 cells. The nuclear counter stain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) at1/1000 dilution and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab199357 at 1/100 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-DR5 antibody [EPR19310] (AB199357)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HCT 116 (Human colorectal carcinoma cell line) cells labeling DR5with ab199357 at 1/70 dilution (red) compared with aRabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HCT 116 (Human colorectal carcinoma cell line) cells labeling DR5 with ab199357 at 1/100 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous and cytoplasmic staining on HCT 116 cells. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab199357 at 1/100 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)
DR5 was immunoprecipitated from 0.35mg of HT1080 (Human fibrosarcoma cell line) treated with 5μM MG132 for 4 hour whole cell lysate with ab199357 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab199357 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HT1080 treated with 5μM MG132 for 4 hour whole cell lysate, 10μg (Input).
Lane 2 : ab199357 IP in HT1080 treated with 5μM MG132 for 4 hour whole cell lysate.
Lane 3 : Rabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab199357 in HT1080 treated with 5μM MG132 for 4 hour whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
All lanes:
Immunoprecipitation - Anti-DR5 antibody [EPR19310] (ab199357)
Predicted band size: 47 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)
DR5 was immunoprecipitated from 0.35mg of HCT 116 (Human colorectal carcinoma cell line) whole cell lysate with ab199357 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab199357 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HCT 116 whole cell lysate, 10μg (Input).
Lane 2 : ab199357 IP in HCT 116 whole cell lysate.
Lane 3 : Rabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab199357 in HCT 116 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
All lanes:
Immunoprecipitation - Anti-DR5 antibody [EPR19310] (ab199357)
Predicted band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1-2 : 3 minutes; Lane 3 : 10 seconds; Lane 4 : 8 seconds.
The expression profile is consistent with what has been described in the literature (PMID : 20515924; PMID : 16297203).
All lanes:
Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution
Lane 1:
Human melanoma lysate at 10 µg
Lane 2:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 3:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg
Lane 4:
HT1080 (Human fibrosarcoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 47 kDa
Observed band size: 40 kDa,48 kDa
false
- WB
Lab
Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
Lanes 1- 2 : Merged signal (red and green). Green - ab199357 observed at 47 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab199357 was shown to react with DR5 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab264922 (knockout cell lysate ab257748) was used. Wild-type HeLa and TNFRSF10B knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab199357 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
DR5 knockout HeLa cell lysate at 20 µg
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Lab
Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
Lanes 1 - 2 : Merged signal (red and green). Green - ab199357 observed at 47 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab199357 was shown to recognize DR5 in wild-type HAP1 cells as signal was lost at the expected MW in TNFRSF10B knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and TNFRSF10B knockout samples were subjected to SDS-PAGE. ab199357 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
TNFRSF10B knockout HAP1 whole cell lysate at 20 µg
Predicted band size: 47 kDa,72 kDa
Observed band size: 120 kDa,72 kDa
false
- WB
Supplier Data
Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
Blocking/Dilution buffer : 5% NFDM/TBST.
Doxorubicin treatment elevated the expression of DR5 (PMID : 12496481; PMID : 11468181; PMID : 11090076). The expression profile is consistent with what has been described in the literature (PMID : 20515924; PMID : 16297203).
All lanes:
Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution
Lane 1:
Untreated HCT 116 (Human colorectal carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
HCT 116 (Human colorectal carcinoma cell line) treated with 0.5μM/ml doxorubicin for 24 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 47 kDa
Observed band size: 40 kDa,48 kDa
false
Exposure time: 8s
Related conjugates and formulations (1)
-
Anti-DR5 antibody [EPR19310] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DR5 plays a significant role in the regulation of apoptosis particularly in cancer cells. It is a component of the TRAIL receptor complex which includes several other death receptors like DR4. This complex formation allows DR5 to mediate apoptotic signals more efficiently. By controlling apoptosis DR5 helps maintain tissue homeostasis and prevents abnormal cell proliferation.
Pathways
DR5 is an important part of the TRAIL signaling pathway and the extrinsic apoptosis pathway. It connects with proteins like FADD and Caspase-8 essential in the apoptotic signaling cascade. By interacting with these proteins DR5 drives the progression of the apoptotic signal ensuring the removal of dysfunctional cells. Such pathways are vital for restraining tumor development and progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (19)
Recent publications for all applications. Explore the full list and refine your search
Avicenna journal of phytomedicine 14:64-77 PubMed38948179
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e23757 PubMed38937960
2024
Applications
Unspecified application
Species
Unspecified reactive species
World journal of gastroenterology 29:1875-1898 PubMed37032730
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 34:211-220 PubMed36511604
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:11213-11224 PubMed34845969
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 37:109953 PubMed34731630
2021
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 16:e0246733 PubMed33661931
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 20:833-845 PubMed33632873
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cytotechnology 73:63-70 PubMed33505114
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 11:522729 PubMed33071777
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com